from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2200c/ctaC

LFCtreatmentdescriptionclass of inhibitor

-1.964

Amikacinug/mL Amikacintranslation

-0.455

Cap5-10ug/mL Capreomycintranslation

-0.747

Rox10-50 ug/mL Roxithromycintranslation

-0.235

SM2-5 ug/mL Streptomycintranslation

-1.246

Tet5-10 ug/mL Tetracyclinetranslation

-0.001

Rif0.2-5ug/mL Rifampicintranscription

-0.481

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.323

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.061

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.212

CPZ10-50 ug/mL Chlorpromazinerespiration

0.346

Clofazimine10-13 ug/mL Clofaziminerespiration

0.722

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.832

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.501

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.041

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.887

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.494

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.642

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.731

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.091

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.716

KCN5-20 ug/mL Potassium cyaniderespiration

0.512

NaN30.2-2 mM Sodium aziderespiration

0.954

Nigericin50 uM Nigericinrespiration

-1.653

TRC10-150 ug/mL Triclosanrespiration

-1.442

TRZ10-25 ug/mL Thioridazinerespiration

-1.078

Valinomycin0.5-10 uM Valinomycinrespiration

1.289

ZnSO42 mM ZnSO4respiration

-0.112

menadione6-10 ug/mL Menadionerespiration

0.511

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.479

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.657

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.721

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.019

NRP_1Non-replicating persistence stage 1dosRassociated

0.825

Amp0.2mg/mL AmpicillincellWall

0.101

Cephalexin20-100 ug/mL CephalexincellWall

1.114

Cerulenin0.32-5 ug/mL CerulenincellWall

0.643

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.823

EMB10-20 ug/mL EthambutolcellWall

0.775

Eta12-40 ug/mL EthionamidecellWall

0.494

INH0.2-0.4 ug/mL IsoniazidcellWall

0.743

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.276

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.782

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.262

BZA0.12 mg/mL BenzamidearomaticAmides

-0.620

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.105

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.158

H2O24 mM hydrogen peroxideDNAdamaging

-0.127

Levo10 ug/mL LevofloxacinDNAdamaging

0.547

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.545

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.064

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.015

UVUV-irradiationDNAdamaging

-0.905

ARP41-4 ug/mL Antitubercular compound ARP4?

0.831

Antimycin12.5-50 ug/mL Antimycin A?

0.435

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.057

PA_110-50 ug/mL Antitubercular compound PA-1?

1.031

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.098

PA8240.2-2 ug/mL PA-824?

-0.854

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.233

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.541

Verapamil50 uM Verapamil?

0.052

mercaptoethanol2 mM 2-Mercaptoethanol?

0.530

methoxatin10-20 ug/mL Methoxatin?